The subject of the next CEPAC meeting in December 2011 will be an adaptation of Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults. The selection of treatment-resistant depression (TRD) was based on discussions with the RAPiD Advisory Board, especially around what topics would likely produce actionable products for medical policymakers. We also based our decision on research we conducted on insurance coverage variation across the states and payers. We then scored our top two topics (TRD and Autism Spectrum Disorders) using a list of topic selection criteria and TRD scored higher overall.
If you or your organization has information, studies or other materials on the topic that ICER should consider as part of its adaptation, please submit them via this website.